2017
DOI: 10.1038/ni.3773
|View full text |Cite
|
Sign up to set email alerts
|

The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage

Abstract: Activated CD8+ T cells differentiate into cytotoxic effector (TEFF) cells that eliminate target cells. How TEFF cell identity is established and maintained remains less understood. Here we show Runx3 deficiency limits clonal expansion and impairs upregulation of cytotoxic molecules in TEFF cells. Runx3-deficient CD8+ TEFF cells aberrantly upregulate genes characteristic of follicular helper T (TFH) cell lineage, including Bcl6, Tcf7 and Cxcr5. Mechanistically, the Runx3-CBFβ complex deploys H3K27me3 to Bcl6 an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
131
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 120 publications
(146 citation statements)
references
References 54 publications
(84 reference statements)
11
131
0
Order By: Relevance
“…This finding corroborates a previous study showing that changes in chromatin accessibility and transcription did not always match as Tregs adapted to different tissues 39 . Nevertheless, our identification of a pre-IEL signature, marked by the loss of key features of conventional CD4 and/or Treg programs, suggests that during tissue adaptation a cell must first shut down transcriptional programs in place (or decouple TFs bound to its DNA targets) that may prevent tissue imprinting, suggestion corroborated by previous studies describing roles of Runx3 to the CD8-lineage or tissue-resident memory T cells (TRM) 26,27 . A recent study also describes a stepwise process taken by Tregs, in which peripheral precursors gradually acquire chromatin accessibility and reprograming towards nonlymphoid-tissue Tregs.…”
Section: Discussionsupporting
confidence: 78%
See 1 more Smart Citation
“…This finding corroborates a previous study showing that changes in chromatin accessibility and transcription did not always match as Tregs adapted to different tissues 39 . Nevertheless, our identification of a pre-IEL signature, marked by the loss of key features of conventional CD4 and/or Treg programs, suggests that during tissue adaptation a cell must first shut down transcriptional programs in place (or decouple TFs bound to its DNA targets) that may prevent tissue imprinting, suggestion corroborated by previous studies describing roles of Runx3 to the CD8-lineage or tissue-resident memory T cells (TRM) 26,27 . A recent study also describes a stepwise process taken by Tregs, in which peripheral precursors gradually acquire chromatin accessibility and reprograming towards nonlymphoid-tissue Tregs.…”
Section: Discussionsupporting
confidence: 78%
“…Accessible chromatin regions with the RUNX binding motif increased during the iTreg to IEL progression, reaching peak significance in clusters 5 and 6. ThPOK downmodulation may leave space for other TF to bind in adjacent DNA regions, a possibility analogous to previously described roles of Runx3 to the CD8-lineage 26,27 . For instance, Runx3 can bind to ThPOK silencer regions that in turn allows for the expression of a CD8 program in thymocytes 28 .…”
Section: Thpok Downmodulation Together With the Epithelial Environmensupporting
confidence: 55%
“…In addition to the HLA region, variants in the ERAP1/2 loci (which encode enzymes required for HLA class I peptide trimming [43][44][45], and the RUNX3 locus, which encodes runt-related transcription factor 3, a transcription factor essential for CD8+ T cell development and differentiation [46][47][48] , are associated with AS and PsA as well as psoriasis [49][50][51][52] . The location of susceptibility variants associated with PsA has been shown to overlap with epigenetic marks of transcription (histone H3 lysine 4 trimethylation (H3K4me3), a histone modification and epigenetic marker of active promoters) in memory CD8+ T cells 52 ; in AS, susceptibility variants overlap with H3K4me3 marks across a range of immune cell types, including CD4+ and CD8+ T cells 53 .…”
Section: Genetics Of Spa With a Focus On The Mhc Class I Pathway And mentioning
confidence: 99%
“…157,158 In addition, Runx3 deploys epigenetic marks (i.e., H3K27me3) to guard the fate of effector CD8 + T cells and prevent the expression of follicular helper T cell-related genes. 159 As to be discussed in the next section, a small population of CD4 + T cells acquire the expression of Runx3 and differentiate into CD8αα + CD4 + T RM cells in the gut IEL compartment. 160,161 More recently, using computational and pooled in vivo RNAi screens, Runx3 is reported to be a critical regulator in the establishment of T RM cell populations in both non-barrier tissues (salivary gland and kidney) and barrier tissues (IEL, skin and lung parenchyma) even though the expression of Runx3 is not specifically induced in T RM cells.…”
Section: Transcriptional Regulation Of Trm Cellsmentioning
confidence: 99%